582P Health-related quality of life (HRQoL) at final analysis of the GALAHAD study of niraparib in patients with metastatic castration-resistant prostate cancer (mCRPC) and DNA repair defects (DRD) — Matthew R. Smith (2021) | RDL Network
582P Health-related quality of life (HRQoL) at final analysis of the GALAHAD study of niraparib in patients with metastatic castration-resistant prostate cancer (mCRPC) and DNA repair defects (DRD)
Matthew R. Smith, Shahneen Sandhu, William Kevin Kelly, Howard I. Scher, Eleni Efstathiou, Primo N. Lara, Evan Y. Yu, Daniel J. George, Kim N., Jason M. Summa, Nishi Kothari, Xin Zhao, Byron M. Espina, Deborah Ricci, Jason S. Simon, NamPhuong Tran, Karim Fizazi
Matthew R. Smith, Shahneen Sandhu, William Kevin Kelly, Howard I. Scher, Eleni Efstathiou, Primo N. Lara, Evan Y. Yu, Daniel J. George, K.N. Chi, Fred Saad, Jason M. Summa, John Freedman, Gary Mason, E Zhu, Deborah Ricci, Jason S. Simon, Shinta Cheng, Karim Fizazi
Matthew R. Smith, Karim Fizazi, Shahneen Sandhu, William Kevin Kelly, Eleni Efstathiou, Primo N. Lara, Evan Y. Yu, Daniel J. George, Kim N., Fred Saad, Jason M. Summa, Jamie Freedman, Gary Mason, Byron M. Espina, Eugene Zhu, Deborah Ricci, Linda A. Snyder, Jason S. Simon, Shinta Cheng, Howard I. Scher
Matthew R. Smith, Shahneen Sandhu, Daniel J. George, Kim Nguyen, Fred Saad, Antoine Thiery-Vuillemin, O. Ståhl, David Olmos, Daniel C. Danila, Rustem Gafanov, Elena Castro, Helen Moon, Anthony M. Joshua, Gary Mason, Byron M. Espina, Yan Liu, Angela Lopez‐Gitlitz, Peter Francis, Katherine B. Bevans, Karim Fizazi
Matthew R. Smith, Howard I. Scher, Shahneen Sandhu, Eleni Efstathiou, Primo N. Lara, Evan Y. Yu, Daniel J. George, Kim N., Fred Saad, Olof Ståhl, David Olmos, Daniel C. Danila, Gary Mason, Byron M. Espina, Xin Zhao, Karen A. Urtishak, Peter Francis, Angela Lopez‐Gitlitz, Karim Fizazi, Francis Parnis, Anthony M. Joshua, Lisa G. Horvath,
Discussion(0)
No comments yet. Be the first to comment.